Health Canada drug identification number

DIN 02495007 — ROZLYTREK 100 MG

ROZLYTREK is a capsule of Entrectinib marketed by HOFFMANN-LA ROCHE LIMITED. The full Entrectinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02495007
Brand name
ROZLYTREK
Active ingredient
Entrectinib
Strength
100 MG
Dosage form
CAPSULE
Route
ORAL
Manufacturer
HOFFMANN-LA ROCHE LIMITED
Health Canada status
MARKETED
Drug class
Tyrosine kinase inhibitor (TRK/ROS1/ALK inhibitor)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Entrectinib products

DINBrandStrengthFormManufacturerStatus
02495015 ROZLYTREK 200 MG CAPSULE HOFFMANN-LA ROCHE LIMITED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.